Interplay between CMVs and interferon signaling: implications for pathogenesis and therapeutic intervention (Q38052946)

27 August 2017

Interplay between CMVs and interferon signaling: implications for pathogenesis and therapeutic intervention (English)

1 reference

27 August 2017

0 references

Vu Thuy Khanh Le

2

0 references

Mirko Trilling

object named as

Mirko Trilling

series ordinal

1

0 references

Hartmut Hengel

series ordinal

3

object named as

Hartmut Hengel

1 reference

27 August 2017

1 November 2012

1 reference

27 August 2017

14

1 reference

inferred from page(s)

published in

Future Microbiology

1 reference

27 August 2017

7

1 reference

27 August 2017

1269-1282

1 reference

27 August 2017

11

1 reference

Viruses know it all: new insights into IFN networks

27 August 2017

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Multifaceted evasion of the interferon response by cytomegalovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Sources and signals regulating type I interferon production: lessons learned from cytomegalovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Identification of proteins in human cytomegalovirus (HCMV) particles: the HCMV proteome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

RNAs are packaged into human cytomegalovirus virions in proportion to their intracellular concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Human cytomegalovirus sequences expressed in latently infected individuals promote a latent infection in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Cytomegalovirus (CMV) seroprevalence in pregnant women, bone marrow donors and adolescents in Germany, 1996-2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Congenital cytomegalovirus mortality in the United States, 1990-2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Hearing loss in children with congenital cytomegalovirus infection born to mothers with preexisting immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Human cytomegalovirus infection is detected frequently in stillbirths and is associated with fetal thrombotic vasculopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Hierarchical and redundant lymphocyte subset control precludes cytomegalovirus replication during latent infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Memory inflation: continuous accumulation of antiviral CD8+ T cells over time.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Sustained CD8+ T cell memory inflation after infection with a single-cycle cytomegalovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Evasion of CD8+ T cells is critical for superinfection by cytomegalovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Initial sequencing and comparative analysis of the mouse genome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

An Atomic Model of the Interferon-β Enhanceosome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Cellular physiology of STAT3: Where's the cytoplasmic monomer?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Tyrosine phosphorylation regulates the partitioning of STAT1 between different dimer conformations

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

DNA binding controls inactivation and nuclear accumulation of the transcription factor Stat1.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Transcriptional profiling of interferon regulatory factor 3 target genes: direct involvement in the regulation of interferon-stimulated genes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

IRF-3-dependent, NFkappa B- and JNK-independent activation of the 561 and IFN-beta genes in response to double-stranded RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Virus interference. I. The interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Human cytomegalovirus interferes with signal transducer and activator of transcription (STAT) 2 protein stability and tyrosine phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

A cytomegaloviral protein reveals a dual role for STAT2 in IFN-{gamma} signaling and antiviral responses

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Synergistic inhibition of human cytomegalovirus replication by interferon-alpha/beta and interferon-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Effect of recombinant human interferon gamma against human cytomegalovirus.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Activation of the transcription factor ISGF3 by interferon-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Two distinct alpha-interferon-dependent signal transduction pathways may contribute to activation of transcription of the guanylate-binding protein gene

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Reversible inhibition of murine cytomegalovirus replication by gamma interferon (IFN-γ) in primary macrophages involves a primed type I IFN-signaling subnetwork for full establishment of an immediate-early antiviral state

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Transcriptional and posttranscriptional regulation of interferon-induced gene expression in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

The interferon stimulated gene 15 functions as a proviral factor for the hepatitis C virus and as a regulator of the IFN response.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Herpes simplex virus-1 induces expression of a novel MxA isoform that enhances viral replication.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

A diverse range of gene products are effectors of the type I interferon antiviral response

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Human cytomegalovirus IE1 protein elicits a type II interferon-like host cell response that depends on activated STAT1 but not interferon-γ

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Two gamma interferon-activated site-like elements in the human cytomegalovirus major immediate-early promoter/enhancer are important for viral replication.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Interferon gamma regulates acute and latent murine cytomegalovirus infection and chronic disease of the great vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Biologic consequences of Stat1-independent IFN signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Novel functions of tyrosine kinase 2 in the antiviral defense against murine cytomegalovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

IFNalpha activates dormant haematopoietic stem cells in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

A lymphotoxin-IFN-beta axis essential for lymphocyte survival revealed during cytomegalovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Inborn errors of human JAKs and STATs

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Severe impairment of IFN-γ and IFN-α responses in cells of a patient with a novel STAT1 splicing mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Heterozygous TBK1 mutations impair TLR3 immunity and underlie herpes simplex encephalitis of childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Gamma interferon-induced interferon regulatory factor 1-dependent antiviral response inhibits vaccinia virus replication in mouse but not human fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Exploitation of herpesviral transactivation allows quantitative reporter gene-based assessment of virus entry and neutralization

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Novel cell type-specific antiviral mechanism of interferon gamma action in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Murine cytomegalovirus m142 and m143 are both required to block protein kinase R-mediated shutdown of protein synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Specific inhibition of the PKR-mediated antiviral response by the murine cytomegalovirus proteins m142 and m143.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

The IFN regulatory factor 7-dependent type I IFN response is not essential for early resistance against murine cytomegalovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Human cytomegalovirus immediate-early 2 protein IE86 blocks virus-induced chemokine expression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Human cytomegalovirus IE86 attenuates virus- and tumor necrosis factor alpha-induced NFkappaB-dependent gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

A human cytomegalovirus antagonist of type I IFN-dependent signal transducer and activator of transcription signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Major human cytomegalovirus structural protein pp65 (ppUL83) prevents interferon response factor 3 activation in the interferon response

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Human cytomegalovirus UL83-coded pp65 virion protein inhibits antiviral gene expression in infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Physical requirements and functional consequences of complex formation between the cytomegalovirus IE1 protein and human STAT2.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

A cytomegalovirus inhibitor of gamma interferon signaling controls immunoproteasome induction

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Murine cytomegalovirus open reading frame M27 plays an important role in growth and virulence in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Controlled clinical trial of prophylactic human-leukocyte interferon in renal transplantation. Effects on cytomegalovirus and herpes simplex virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Double-blind, placebo-controlled trial of human lymphoblastoid interferon prophylaxis of cytomegalovirus infection in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Human cytomegalovirus infection inhibits response of chronic hepatitis-C-virus-infected patients to interferon-based therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

A novel type of influenza vaccine: safety and immunogenicity of replication-deficient influenza virus created by deletion of the interferon antagonist NS1.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Enforced viral replication activates adaptive immunity and is essential for the control of a cytopathic virus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Targeted deletion of regions rich in immune-evasive genes from the cytomegalovirus genome as a novel vaccine strategy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

A replicating cytomegalovirus-based vaccine encoding a single Ebola virus nucleoprotein CTL epitope confers protection against Ebola virus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Identification of DNA-damage DNA-binding protein 1 as a conditional essential factor for cytomegalovirus replication in interferon-γ-stimulated cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Human cytomegalovirus pp71 stimulates cell cycle progression by inducing the proteasome-dependent degradation of the retinoblastoma family of tumor suppressors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Proteasome inhibitor MG132 blocks viral DNA replication and assembly of human cytomegalovirus.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Bortezomib: proteasome inhibition as an effective anticancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Chemical genetics screen for enhancers of rapamycin identifies a specific inhibitor of an SCF family E3 ubiquitin ligase

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

An allosteric inhibitor of substrate recognition by the SCFCdc4 ubiquitin ligase

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Small-molecule inhibition of human immunodeficiency virus type 1 replication by targeting the interaction between Vif and ElonginC.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Human cytomegalovirus pUL83 stimulates activity of the viral immediate-early promoter through its interaction with the cellular IFI16 protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10)

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

A novel viral transcript with homology to human interleukin-10 is expressed during latent human cytomegalovirus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Inhibition of 2',5'-oligoadenylate synthetase expression and function by the human cytomegalovirus ORF94 gene product.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Human cytomegalovirus TRS1 and IRS1 gene products block the double-stranded-RNA-activated host protein shutoff response induced by herpes simplex virus type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Binding and nuclear relocalization of protein kinase R by human cytomegalovirus TRS1.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Viral mediated redirection of NEMO/IKKγ to autophagosomes curtails the inflammatory cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

The ribonucleotide reductase R1 homolog of murine cytomegalovirus is not a functional enzyme subunit but is required for pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Inhibition of proinflammatory and innate immune signaling pathways by a cytomegalovirus RIP1-interacting protein

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Cytomegalovirus M45 cell death suppression requires receptor-interacting protein (RIP) homotypic interaction motif (RHIM)-dependent interaction with RIP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Murine cytomegalovirus paralyzes macrophages by blocking IFN gamma-induced promoter assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Rhesus cytomegalovirus particles prevent activation of interferon regulatory factor 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

Mouse cytomegalovirus inhibits beta interferon (IFN- ) gene expression and controls activation pathways of the IFN- enhanceosome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.109

https://api.fatcat.wiki/v0/release/ighawxiikfc2nnyxybhxycc6yu

21 January 2018

Identifiers

1 reference

30 July 2022

mapped directly with Wikidata item

Fatcat ID

release_ighawxiikfc2nnyxybhxycc6yu

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ighawxiikfc2nnyxybhxycc6yu

30 July 2022

mapped directly with Wikidata item

1 reference

https://api.fatcat.wiki/v0/release/ighawxiikfc2nnyxybhxycc6yu

30 July 2022